[S02DA03, antipyrine, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Antipyrine.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Nitroglycerin.]
[J01EC02, sulfadiazine, The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Nitroglycerin.]
[J01EC01, sulfamethoxazole, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Sulfamethoxazole.]
[J01EB04, sulfapyridine, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Sulfapyridine.]
[M01AB02, sulindac, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Sulindac.]
[M01AX04, apazone, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Azapropazone.]
[R03CC03, terbutaline, Terbutaline may decrease the antihypertensive activities of Nitroglycerin.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Tetracaine.]
[N05AE05, lurasidone, Lurasidone may decrease the antihypertensive activities of Nitroglycerin.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Apomorphine is combined with Nitroglycerin.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Thalidomide.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Nitroglycerin.]
[N05AB08, thioproperazine, Thioproperazine may decrease the antihypertensive activities of Nitroglycerin.]
[N05AC02, thioridazine, Thioridazine may decrease the antihypertensive activities of Nitroglycerin.]
[G04BE06, moxisylyte, Moxisylyte may decrease the antihypertensive activities of Nitroglycerin.]
[S01ED01, timolol, Timolol may increase the hypotensive activities of Nitroglycerin.]
[M02AX02, tolazoline, Tolazoline may decrease the antihypertensive activities of Nitroglycerin.]
[M02AA21, tolmetin, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Tolmetin.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the hypotensive activities of Nitroglycerin.]
[N06AX05, trazodone, Trazodone may decrease the antihypertensive activities of Nitroglycerin.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Tretinoin.]
[C03DB02, triamterene, The risk or severity of adverse effects can be increased when Triamterene is combined with Nitroglycerin.]
[C03AA06, trichlormethiazide, The therapeutic efficacy of Nitroglycerin can be increased when used in combination with Trichlormethiazide.]
[N05AB06, trifluoperazine, Trifluoperazine may decrease the antihypertensive activities of Nitroglycerin.]
[A03AA05, trimebutine, Trimebutine may increase the vasodilatory activities of Nitroglycerin.]
[S01ED04, metipranolol, Nitroglycerin may increase the hypotensive activities of Metipranolol.]
[N03AC02, trimethadione, Trimethadione may increase the vasodilatory activities of Nitroglycerin.]
[C02BA01, trimethaphan, Nitroglycerin may increase the hypotensive activities of Trimethaphan.]
[N06AA06, trimipramine, Trimipramine may decrease the antihypertensive activities of Nitroglycerin.]
[N06AX24, vilazodone, Vilazodone may decrease the antihypertensive activities of Nitroglycerin.]
[C09CA09, azilsartan medoxomil, Nitroglycerin may increase the hypotensive activities of Azilsartan medoxomil.]
[R03AC18, indacaterol, Indacaterol may decrease the antihypertensive activities of Nitroglycerin.]
[C08DA01, verapamil, Verapamil may increase the vasodilatory activities of Nitroglycerin.]
[C04AX07, vincamine, Nitroglycerin may increase the hypotensive activities of Vincamine.]
[N01AX15, xenon, Xenon may decrease the antihypertensive activities of Nitroglycerin.]
[C03BA10, xipamide, Nitroglycerin may increase the hypotensive activities of Xipamide.]
[N05AF05, zuclopenthixol, Zuclopenthixol may decrease the antihypertensive activities of Nitroglycerin.]
[N05AE04, ziprasidone, Ziprasidone may increase the antihypertensive activities of Nitroglycerin.]
[N02BA01, aspirin, The serum concentration of Nitroglycerin can be increased when it is combined with Acetylsalicylic acid.]
[C07AB03, atenolol, Atenolol may increase the hypotensive activities of Nitroglycerin.]
[L01FA01, rituximab, Nitroglycerin may increase the hypotensive activities of Rituximab.]
[S01FA01, atropine, Atropine may decrease the antihypertensive activities of Nitroglycerin.]
[G04BE10, avanafil, Avanafil may increase the hypotensive activities of Nitroglycerin.]
[M03BX01, baclofen, The risk or severity of adverse effects can be increased when Baclofen is combined with Nitroglycerin.]
[G04BD12, mirabegron, Mirabegron may decrease the antihypertensive activities of Nitroglycerin.]
[C01CA18, octopamine, Octopamine may decrease the antihypertensive activities of Nitroglycerin.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Nitroglycerin.]
[S01GA07, brimonidine, Brimonidine may increase the antihypertensive activities of Nitroglycerin.]
[N04BD02, rasagiline, Rasagiline may increase the hypotensive activities of Nitroglycerin.]
[C08CA13, lercanidipine, Lercanidipine may increase the vasodilatory activities of Nitroglycerin.]
[N02CC03, zolmitriptan, Zolmitriptan may decrease the antihypertensive activities of Nitroglycerin.]
[N01AA01, ethyl ether, Diethyl ether may decrease the antihypertensive activities of Nitroglycerin.]
[G04BE03, sildenafil, The risk or severity of hypotension can be increased when Nitroglycerin is combined with Sildenafil.]
[C04AX11, bencyclane, Bencyclane may increase the vasodilatory activities of Nitroglycerin.]
[C03AA01, bendroflumethiazide, The therapeutic efficacy of Nitroglycerin can be increased when used in combination with Bendroflumethiazide.]
[N02BA10, benorilate, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Benorilate.]
[A10BK02, canagliflozin, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Canagliflozin.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Benzocaine.]
[M01AH01, celecoxib, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Celecoxib.]
[N02CC02, naratriptan, Naratriptan may decrease the antihypertensive activities of Nitroglycerin.]
[R02AX03, benzydamine, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Benzydamine.]
[C08EA02, bepridil, Bepridil may increase the vasodilatory activities of Nitroglycerin.]
[C02KX05, riociguat, Nitroglycerin may increase the hypotensive activities of Riociguat.]
[C02KX04, macitentan, Nitroglycerin may increase the hypotensive activities of Macitentan.]
[N06AX26, vortioxetine, Vortioxetine may decrease the antihypertensive activities of Nitroglycerin.]
[A10BK01, dapagliflozin, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Dapagliflozin.]
[C01CA27, droxidopa, Droxidopa may decrease the antihypertensive activities of Nitroglycerin.]
[C07AB04, acebutolol, Nitroglycerin may increase the hypotensive activities of Acebutolol.]
[S01ED02, betaxolol, Betaxolol may increase the hypotensive activities of Nitroglycerin.]
[C02CC01, bethanidine, Bethanidine may decrease the antihypertensive activities of Nitroglycerin.]
[A10BK03, empagliflozin, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Empagliflozin.]
[R03AC19, olodaterol, Olodaterol may decrease the antihypertensive activities of Nitroglycerin.]
[S01EE02, unoprostone, Nitroglycerin may increase the hypotensive activities of Unoprostone.]
[N05AA04, acepromazine, Acepromazine may decrease the antihypertensive activities of Nitroglycerin.]
[N06AX11, mirtazapine, Mirtazapine may decrease the antihypertensive activities of Nitroglycerin.]
[N02BE01, acetaminophen, The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Nitroglycerin.]
[N05AX16, brexpiprazole, Brexpiprazole may decrease the antihypertensive activities of Nitroglycerin.]
[G02CX02, flibanserin, Flibanserin may decrease the antihypertensive activities of Nitroglycerin.]
[N05AX15, cariprazine, Cariprazine may decrease the antihypertensive activities of Nitroglycerin.]
[M02AA25, aceclofenac, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Aceclofenac.]
[M01AB11, acemetacin, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Acemetacin.]
[B01AC27, selexipag, Nitroglycerin may increase the hypotensive activities of Selexipag.]
[G04CA01, alfuzosin, Alfuzosin may increase the hypotensive activities of Nitroglycerin.]
[M01AE16, alminoprofen, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Alminoprofen.]
[N04BC01, bromocriptine, The bioavailability of Bromocriptine can be increased when combined with Nitroglycerin.]
[N06AA19, amineptin, Amineptine may decrease the antihypertensive activities of Nitroglycerin.]
[C08CA01, amlodipine, Amlodipine may increase the vasodilatory activities of Nitroglycerin.]
[C03CA02, bumetanide, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Bumetanide.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Nitroglycerin.]
[C07AA19, bupranolol, Nitroglycerin may increase the hypotensive activities of Bupranolol.]
[N05BE01, buspirone, Buspirone may decrease the antihypertensive activities of Nitroglycerin.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Arsenic trioxide.]
[A07EC04, balsalazide, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Balsalazide.]
[R03CC12, bambuterol, Bambuterol may decrease the antihypertensive activities of Nitroglycerin.]
[C09AA07, benazepril, Benazepril may increase the hypotensive activities of Nitroglycerin.]
[J01XX08, linezolid, Linezolid may increase the hypotensive activities of Nitroglycerin.]
[N04BD03, safinamide, Safinamide may increase the hypotensive activities of Nitroglycerin.]
[C07AB07, bisoprolol, Bisoprolol may increase the hypotensive activities of Nitroglycerin.]
[R03AC17, bitolterol, Bitolterol may decrease the antihypertensive activities of Nitroglycerin.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Nesiritide.]
[C04AX20, buflomedil, Buflomedil may decrease the antihypertensive activities of Nitroglycerin.]
[M01AB07, bumadizone, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Bumadizone.]
[N06AA15, butriptyline, Butriptyline may decrease the antihypertensive activities of Nitroglycerin.]
[C09AA01, captopril, Nitroglycerin may increase the hypotensive activities of Captopril.]
[C07AG02, carvedilol, Carvedilol may increase the vasodilatory activities of Nitroglycerin.]
[B02BX09, fostamatinib, The risk or severity of hypotension can be increased when Fostamatinib is combined with Nitroglycerin.]
[N03AX24, cannabidiol, Cannabidiol may decrease the antihypertensive activities of Nitroglycerin.]
[C07AB08, celiprolol, Nitroglycerin may increase the hypotensive activities of Celiprolol.]
[M01AC05, lornoxicam, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Lornoxicam.]
[C09AA08, cilazapril, Nitroglycerin may increase the hypotensive activities of Cilazapril.]
[A03FA08, cinitapride, Cinitapride may decrease the antihypertensive activities of Nitroglycerin.]
[S01ED05, carteolol, Carteolol may increase the hypotensive activities of Nitroglycerin.]
[L04AA42, siponimod, Siponimod may decrease the antihypertensive activities of Nitroglycerin.]
[N06BA14, solriamfetol, Solriamfetol may decrease the antihypertensive activities of Nitroglycerin.]
[C09CA06, candesartan, Nitroglycerin may increase the hypotensive activities of Candesartan.]
[C03BX03, cicletanine, Nitroglycerin may increase the hypotensive activities of Cicletanine.]
[C03AA09, cyclothiazide, The therapeutic efficacy of Nitroglycerin can be increased when used in combination with Cyclothiazide.]
[G04BE04, yohimbine, Yohimbine may decrease the antihypertensive activities of Nitroglycerin.]
[N02CC07, frovatriptan, Frovatriptan may decrease the antihypertensive activities of Nitroglycerin.]
[G04CB02, dutasteride, Dutasteride may decrease the antihypertensive activities of Nitroglycerin.]
[N02CC06, eletriptan, Eletriptan may decrease the antihypertensive activities of Nitroglycerin.]
[M01AH02, rofecoxib, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Rofecoxib.]
[C08CA16, clevidipine, Clevidipine may increase the vasodilatory activities of Nitroglycerin.]
[C01BD07, dronedarone, Dronedarone may decrease the antihypertensive activities of Nitroglycerin.]
[C02AA06, methoserpidine, Nitroglycerin may increase the hypotensive activities of Methoserpidine.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Opicapone.]
[C01CA14, dopexamine, Dopexamine may decrease the antihypertensive activities of Nitroglycerin.]
[M01AC04, droxicam, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Droxicam.]
[L01EX22, selpercatinib, Selpercatinib may decrease the antihypertensive activities of Nitroglycerin.]
[M02AA27, dexketoprofen, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Dexketoprofen.]
[C08CA17, levamlodipine, Levamlodipine may increase the vasodilatory activities of Nitroglycerin.]
[P01BA01, chloroquine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Nitroglycerin.]
[C03AA04, chlorothiazide, The therapeutic efficacy of Nitroglycerin can be increased when used in combination with Chlorothiazide.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the antihypertensive activities of Nitroglycerin.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the hypotensive activities of Nitroglycerin.]
[N02BA07, ethenzamide, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Ethenzamide.]
[N06BX18, vinpocetine, Vinpocetine may increase the vasodilatory activities of Nitroglycerin.]
[M01AB08, etodolac, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Etodolac.]
[M02AA06, etofenamate, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Etofenamate.]
[L01FX21, naxitamab, Naxitamab may decrease the antihypertensive activities of Nitroglycerin.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Vericiguat.]
[M01AE05, fenbufen, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Fenbufen.]
[C01CA19, fenoldopam, Nitroglycerin may increase the hypotensive activities of Fenoldopam.]
[N06BA08, fenozolone, Fenozolone may decrease the antihypertensive activities of Nitroglycerin.]
[G04CB01, finasteride, Finasteride may decrease the antihypertensive activities of Nitroglycerin.]
[R03CC15, formoterol, Formoterol may decrease the antihypertensive activities of Nitroglycerin.]
[N01AB05, trichloroethylene, Trichloroethylene may decrease the antihypertensive activities of Nitroglycerin.]
[H04AA02, dasiglucagon, Nitroglycerin may increase the hypotensive activities of Dasiglucagon.]
[N07CA02, cinnarizine, Cinnarizine may increase the vasodilatory activities of Nitroglycerin.]
[R03CC13, clenbuterol, Clenbuterol may decrease the antihypertensive activities of Nitroglycerin.]
[B01AD11, tenecteplase, The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Nitroglycerin.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Levobupivacaine.]
[N06AA04, clomipramine, Clomipramine may decrease the antihypertensive activities of Nitroglycerin.]
[S01EA04, clonidine, The risk or severity of hypotension can be increased when Clonidine is combined with Nitroglycerin.]
[N05AH02, clozapine, Clozapine may decrease the antihypertensive activities of Nitroglycerin.]
[C02KB01, metyrosine, Nitroglycerin may increase the hypotensive activities of Metyrosine.]
[M01AX13, proquazone, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Proquazone.]
[N01AB07, desflurane, Desflurane may decrease the antihypertensive activities of Nitroglycerin.]
[C04AX28, ifenprodil, Ifenprodil may decrease the antihypertensive activities of Nitroglycerin.]
[N02BA16, imidazole-2-hydroxybenzoate, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Imidazole salicylate.]
[B01AC10, indobufen, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Indobufen.]
[M01AH03, valdecoxib, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Valdecoxib.]
[A03AX10, isometheptene, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Isometheptene.]
[N02CC05, almotriptan, Almotriptan may decrease the antihypertensive activities of Nitroglycerin.]
[M01AH04, parecoxib, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Parecoxib.]
[M01AA06, kebuzone, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Kebuzone.]
[S01EE04, travoprost, Travoprost may increase the hypotensive activities of Nitroglycerin.]
[S01EE03, bimatoprost, Nitroglycerin may increase the hypotensive activities of Bimatoprost.]
[C08CA09, lacidipine, Nitroglycerin may increase the hypotensive activities of Lacidipine.]
[V03AF07, rasburicase, The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Nitroglycerin.]
[N07BC04, lofexidine, Lofexidine may decrease the antihypertensive activities of Nitroglycerin.]
[M01AB09, lonazolac, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Lonazolac.]
[M02AA31, loxoprofen, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Loxoprofen.]
[C09AA03, lisinopril, Lisinopril may increase the hypotensive activities of Nitroglycerin.]
[C08CA11, manidipine, Manidipine may increase the vasodilatory activities of Nitroglycerin.]
[A08AA09, mefenorex, Mefenorex may decrease the antihypertensive activities of Nitroglycerin.]
[C04AX01, cyclandelate, Cyclandelate may increase the vasodilatory activities of Nitroglycerin.]
[R03CB02, methoxyphenamine, Methoxyphenamine may decrease the antihypertensive activities of Nitroglycerin.]
[C03DA04, eplerenone, Eplerenone may increase the hypotensive activities of Nitroglycerin.]
[C03AA07, cyclopenthiazide, The therapeutic efficacy of Nitroglycerin can be increased when used in combination with Cyclopenthiazide.]
[L01AA01, cyclophosphamide, The risk or severity of methemoglobinemia can be increased when Cyclophosphamide is combined with Nitroglycerin.]
[N06AX07, minaprine, Minaprine may increase the hypotensive activities of Nitroglycerin.]
[S01XA18, cyclosporine, Cyclosporine may decrease the antihypertensive activities of Nitroglycerin.]
[N06AG02, moclobemide, Moclobemide may increase the hypotensive activities of Nitroglycerin.]
[C09AA13, moexipril, Moexipril may increase the hypotensive activities of Nitroglycerin.]
[M02AA02, mofebutazone, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Mofebutazone.]
[M01AX22, morniflumate, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Morniflumate.]
[C03XA02, conivaptan, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Conivaptan.]
[C02AC05, moxonidine, Moxonidine may decrease the antihypertensive activities of Nitroglycerin.]
[G04BE09, vardenafil, The risk or severity of hypotension can be increased when Vardenafil is combined with Nitroglycerin.]
[M01AH05, etoricoxib, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Etoricoxib.]
[J04BA02, dapsone, The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Nitroglycerin.]
[C02CC04, debrisoquin, Nitroglycerin may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, The risk or severity of adverse effects can be increased when Nabilone is combined with Nitroglycerin.]
[M01AX01, nabumetone, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Nabumetone.]
[C07AB12, nebivolol, Nitroglycerin may increase the hypotensive activities of Nebivolol.]
[N06AX06, nefazodone, Nefazodone may decrease the antihypertensive activities of Nitroglycerin.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Nitroglycerin.]
[C01CA23, theodrenaline, Theodrenaline may decrease the antihypertensive activities of Nitroglycerin.]
[C01CA05, norfenefrine, Norfenefrine may decrease the antihypertensive activities of Nitroglycerin.]
[G04BD08, solifenacin, Solifenacin may decrease the antihypertensive activities of Nitroglycerin.]
[A07EC03, olsalazine, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Olsalazine.]
[N06AA01, desipramine, Desipramine may decrease the antihypertensive activities of Nitroglycerin.]
[H01BA02, desmopressin, Desmopressin may decrease the antihypertensive activities of Nitroglycerin.]
[C09XA02, aliskiren, Nitroglycerin may increase the hypotensive activities of Aliskiren.]
[M01AE12, oxaprozin, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Oxaprozin.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the antihypertensive activities of Nitroglycerin.]
[V03AH01, diazoxide, Diazoxide may increase the hypotensive activities of Nitroglycerin.]
[N06AA08, dibenzepin, Dibenzepin may decrease the antihypertensive activities of Nitroglycerin.]
[S01EC02, dichlorphenamide, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Diclofenamide.]
[S01BC03, diclofenac, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Diclofenac.]
[C02DG01, pinacidil, Nitroglycerin may increase the hypotensive activities of Pinacidil.]
[A03AX04, pinaverium, Pinaverium may increase the vasodilatory activities of Nitroglycerin.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Pipamperone.]
[R03CC07, pirbuterol, Pirbuterol may decrease the antihypertensive activities of Nitroglycerin.]
[A08AA03, diethylpropion, Diethylpropion may decrease the antihypertensive activities of Nitroglycerin.]
[C08CA03, isradipine, Isradipine may increase the vasodilatory activities of Nitroglycerin.]
[N02BA11, diflunisal, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Diflunisal.]
[C02DB01, dihydralazine, Nitroglycerin may increase the hypotensive activities of Dihydralazine.]
[C04AE04, dihydroergocristine, The bioavailability of Dihydroergocristine can be increased when combined with Nitroglycerin.]
[N02CA01, dihydroergotamine, The bioavailability of Dihydroergotamine can be increased when combined with Nitroglycerin.]
[B01AC21, treprostinil, Treprostinil may increase the hypotensive activities of Nitroglycerin.]
[C08DB01, diltiazem, Diltiazem may increase the vasodilatory activities of Nitroglycerin.]
[R03CC08, procaterol, Procaterol may decrease the antihypertensive activities of Nitroglycerin.]
[N02BB04, propyphenazone, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Propyphenazone.]
[M01AB14, proglumetacin, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Proglumetacin.]
[C09AA06, quinapril, Nitroglycerin may increase the hypotensive activities of Quinapril.]
[B01AC07, dipyridamole, The risk or severity of hypotension can be increased when Dipyridamole is combined with Nitroglycerin.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may decrease the antihypertensive activities of Nitroglycerin.]
[N06AA23, quinupramine, Quinupramine may decrease the antihypertensive activities of Nitroglycerin.]
[C09AA05, ramipril, Ramipril may increase the hypotensive activities of Nitroglycerin.]
[R03CC14, reproterol, Reproterol may decrease the antihypertensive activities of Nitroglycerin.]
[N05AX08, risperidone, Nitroglycerin may increase the hypotensive activities of Risperidone.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Ropivacaine is combined with Nitroglycerin.]
[G04BE08, tadalafil, The risk or severity of hypotension can be increased when Tadalafil is combined with Nitroglycerin.]
[S01BC05, ketorolac, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Ketorolac.]
[C02KX02, ambrisentan, Nitroglycerin may increase the hypotensive activities of Ambrisentan.]
[N02BA06, salsalate, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Salsalate.]
[R03AC12, salmeterol, Salmeterol may decrease the antihypertensive activities of Nitroglycerin.]
[C01CA07, dobutamine, Dobutamine may decrease the antihypertensive activities of Nitroglycerin.]
[C01CA04, dopamine, Dopamine may decrease the antihypertensive activities of Nitroglycerin.]
[N06AA16, dothiepin, Dosulepin may decrease the antihypertensive activities of Nitroglycerin.]
[R07AB01, doxapram, Doxapram may decrease the antihypertensive activities of Nitroglycerin.]
[N06AA12, doxepin, Doxepin may decrease the antihypertensive activities of Nitroglycerin.]
[N01AB08, sevoflurane, Sevoflurane may decrease the antihypertensive activities of Nitroglycerin.]
[N05AD08, droperidol, Droperidol may decrease the antihypertensive activities of Nitroglycerin.]
[C09AA11, spirapril, Nitroglycerin may increase the hypotensive activities of Spirapril.]
[N02CC01, sumatriptan, Sumatriptan may decrease the antihypertensive activities of Nitroglycerin.]
[C07AB13, talinolol, Nitroglycerin may increase the hypotensive activities of Talinolol.]
[M01AC02, tenoxicam, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Tenoxicam.]
[G04CA03, terazosin, Nitroglycerin may increase the hypotensive activities of Terazosin.]
[G04BD05, terodiline, Terodiline may increase the vasodilatory activities of Nitroglycerin.]
[S01GA02, tetrahydrozoline, Tetryzoline may decrease the antihypertensive activities of Nitroglycerin.]
[N06AX14, tianeptine, Tianeptine may decrease the antihypertensive activities of Nitroglycerin.]
[C09AA02, enalapril, Enalapril may increase the hypotensive activities of Nitroglycerin.]
[M01AG02, tolfenamic acid, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Tolfenamic acid.]
[N06AG03, toloxatone, Toloxatone may increase the hypotensive activities of Nitroglycerin.]
[N06BA09, atomoxetine, Atomoxetine may decrease the antihypertensive activities of Nitroglycerin.]
[C03CA04, torsemide, Torasemide may increase the hypotensive activities of Nitroglycerin.]
[R01AA09, tramazoline, Tramazoline may decrease the antihypertensive activities of Nitroglycerin.]
[C09AA10, trandolapril, Trandolapril may increase the hypotensive activities of Nitroglycerin.]
[R03CC11, tulobuterol, Tulobuterol may decrease the antihypertensive activities of Nitroglycerin.]
[C02CA06, urapidil, Urapidil may decrease the antihypertensive activities of Nitroglycerin.]
[S01FB02, ephedrine, Ephedrine may decrease the antihypertensive activities of Nitroglycerin.]
[C01CX07, xamoterol, Xamoterol may decrease the antihypertensive activities of Nitroglycerin.]
[S01GA03, xylometazoline, Xylometazoline may decrease the antihypertensive activities of Nitroglycerin.]
[C08CA12, mepirodipine, Nitroglycerin may increase the antihypertensive activities of Barnidipine.]
[S01EA01, epinephrine, Epinephrine may decrease the antihypertensive activities of Nitroglycerin.]
[C09AA15, zofenopril, Nitroglycerin may increase the hypotensive activities of Zofenopril.]
[M01AB04, zomepirac, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Zomepirac.]
[N03AX15, zonisamide, Zonisamide may increase the vasodilatory activities of Nitroglycerin.]
[N05CF01, zopiclone, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Zopiclone.]
[C02AC02, guanfacine, Guanfacine may decrease the antihypertensive activities of Nitroglycerin.]
[B01AC11, iloprost, Iloprost may increase the hypotensive activities of Nitroglycerin.]
[G02AB03, ergonovine, The bioavailability of Ergometrine can be increased when combined with Nitroglycerin.]
[C04AE01, ergoloid mesylates, USP, The bioavailability of Ergoloid mesylate can be increased when combined with Nitroglycerin.]
[N02CA02, ergotamine, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Ergotamine.]
[N03AG01, valproic acid, The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Nitroglycerin.]
[C01CA15, gepefrine, Gepefrine may decrease the antihypertensive activities of Nitroglycerin.]
[V03AF05, amifostine, Nitroglycerin may increase the hypotensive activities of Amifostine.]
[N03AD01, ethosuximide, Ethosuximide may increase the vasodilatory activities of Nitroglycerin.]
[M01AC06, meloxicam, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Meloxicam.]
[C01CA01, etilefrine, Etilefrine may decrease the antihypertensive activities of Nitroglycerin.]
[N01AX07, etomidate, Etomidate may decrease the antihypertensive activities of Nitroglycerin.]
[C08CA02, felodipine, Felodipine may increase the vasodilatory activities of Nitroglycerin.]
[C08EA01, fendiline, Fendiline may increase the vasodilatory activities of Nitroglycerin.]
[M01AE04, fenoprofen, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Fenoprofen.]
[R03CC04, fenoterol, Fenoterol may decrease the antihypertensive activities of Nitroglycerin.]
[N02AB03, fentanyl, Fentanyl may decrease the antihypertensive activities of Nitroglycerin.]
[R03CC02, albuterol, Salbutamol may decrease the antihypertensive activities of Nitroglycerin.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Nitroglycerin.]
[N02BG04, floctafenine, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Floctafenine.]
[N07CA03, flunarizine, Flunarizine may increase the vasodilatory activities of Nitroglycerin.]
[N06AA14, melitracen, Melitracen may decrease the antihypertensive activities of Nitroglycerin.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive and vasodilatory activities of Nitroglycerin.]
[N05AF01, flupenthixol, Flupentixol may decrease the antihypertensive activities of Nitroglycerin.]
[S01BC04, flurbiprofen, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Flurbiprofen.]
[N05AG01, fluspirilene, Fluspirilene may increase the vasodilatory activities of Nitroglycerin.]
[L02BB01, flutamide, The risk or severity of methemoglobinemia can be increased when Flutamide is combined with Nitroglycerin.]
[N06BX17, adrafinil, Adrafinil may decrease the antihypertensive activities of Nitroglycerin.]
[G01AX06, furazolidone, Furazolidone may increase the hypotensive activities of Nitroglycerin.]
[C03CA01, furosemide, Furosemide may increase the hypotensive activities of Nitroglycerin.]
[C08DA02, gallopamil, Gallopamil may increase the vasodilatory activities of Nitroglycerin.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Nitroglycerin.]
[N04BC06, cabergoline, The bioavailability of Cabergoline can be increased when combined with Nitroglycerin.]
[N03AD03, methsuximide, Methsuximide may increase the vasodilatory activities of Nitroglycerin.]
[N01AH02, alfentanil, Alfentanil may decrease the antihypertensive activities of Nitroglycerin.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the antihypertensive activities of Nitroglycerin.]
[M01AG01, mefenamic acid, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Mefenamic acid.]
[C02CA04, doxazosin, Doxazosin may increase the hypotensive activities of Nitroglycerin.]
[C07AB09, esmolol, Esmolol may increase the hypotensive activities of Nitroglycerin.]
[C09AA09, fosinopril, Fosinopril may increase the hypotensive activities of Nitroglycerin.]
[S01EX01, guanethidine, Nitroglycerin may increase the hypotensive activities of Guanethidine.]
[N01AB01, halothane, Halothane may decrease the antihypertensive activities of Nitroglycerin.]
[N05AH04, quetiapine, Quetiapine may increase the hypotensive activities of Nitroglycerin.]
[C09CA01, losartan, Losartan may increase the hypotensive activities of Nitroglycerin.]
[S01XA14, heparin, Nitroglycerin may decrease the anticoagulant activities of Heparin.]
[A07EC02, mesalamine, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Mesalazine.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Nitroglycerin.]
[R03CC05, hexoprenaline, Hexoprenaline may decrease the antihypertensive activities of Nitroglycerin.]
[C08CA10, nilvadipine, Nilvadipine may increase the vasodilatory activities of Nitroglycerin.]
[M02AA26, nimesulide, Nimesulide may increase the vasodilatory activities of Nitroglycerin.]
[C09AA04, perindopril, Nitroglycerin may increase the hypotensive activities of Perindopril.]
[C02DB02, hydralazine, Nitroglycerin may increase the hypotensive activities of Hydralazine.]
[C03AA03, hydrochlorothiazide, The therapeutic efficacy of Nitroglycerin can be increased when used in combination with Hydrochlorothiazide.]
[C03AA02, hydroflumethiazide, The therapeutic efficacy of Nitroglycerin can be increased when used in combination with Hydroflumethiazide.]
[G04BD06, propiverine, Propiverine may decrease the antihypertensive activities of Nitroglycerin.]
[L01XX05, hydroxyurea, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Hydroxyurea.]
[C02AC06, rilmenidine, Rilmenidine may decrease the antihypertensive activities of Nitroglycerin.]
[R02AX02, ibuprofen, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Ibuprofen.]
[L01AA06, ifosfamide, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Ifosfamide.]
[N01AH03, sufentanil, Sufentanil may decrease the antihypertensive activities of Nitroglycerin.]
[N06AA02, imipramine, Imipramine may decrease the antihypertensive activities of Nitroglycerin.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Paclitaxel.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Tizanidine is combined with Nitroglycerin.]
[C03BA11, indapamide, The therapeutic efficacy of Indapamide can be increased when used in combination with Nitroglycerin.]
[S01BC01, indomethacin, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Indomethacin.]
[C02CA02, indoramin, Indoramin may decrease the antihypertensive activities of Nitroglycerin.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Articaine.]
[C07AA01, alprenolol, Nitroglycerin may increase the hypotensive activities of Alprenolol.]
[N06AA13, iprindole, Iprindole may decrease the antihypertensive activities of Nitroglycerin.]
[N06AF05, iproniazid, Iproniazid may increase the hypotensive activities of Nitroglycerin.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the hypotensive activities of Nitroglycerin.]
[S01EC03, dorzolamide, Nitroglycerin may increase the hypotensive activities of Dorzolamide.]
[R03CC06, isoetharine, Isoetharine may decrease the antihypertensive activities of Nitroglycerin.]
[C09AA16, imidapril, Nitroglycerin may increase the hypotensive activities of Imidapril.]
[N01AB06, isoflurane, Isoflurane may decrease the antihypertensive activities of Nitroglycerin.]
[R03CB01, isoproterenol, Isoprenaline may decrease the antihypertensive activities of Nitroglycerin.]
[C05AE02, isosorbide dinitrate, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Isosorbide dinitrate.]
[C04AA01, isoxsuprine, Isoxsuprine may decrease the antihypertensive activities of Nitroglycerin.]
[C02KD01, ketanserin, Nitroglycerin may increase the hypotensive activities of Ketanserin.]
[N05AH03, olanzapine, The risk or severity of adverse effects can be increased when Olanzapine is combined with Nitroglycerin.]
[M02AA10, ketoprofen, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Ketoprofen.]
[C01CA22, arbutamine, Arbutamine may decrease the antihypertensive activities of Nitroglycerin.]
[N04BC09, rotigotine, Rotigotine may decrease the antihypertensive activities of Nitroglycerin.]
[C07AG01, labetalol, Labetalol may increase the hypotensive activities of Nitroglycerin.]
[C02AA05, deserpidine, Nitroglycerin may increase the hypotensive activities of Deserpidine.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Nitroglycerin is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Lidocaine is combined with Nitroglycerin.]
[C08EX01, lidoflazine, Lidoflazine may increase the vasodilatory activities of Nitroglycerin.]
[C03DB01, amiloride, The risk or severity of adverse effects can be increased when Amiloride is combined with Nitroglycerin.]
[N02CA07, lisuride, The bioavailability of Lisuride can be increased when combined with Nitroglycerin.]
[N06AA07, lofepramine, Lofepramine may decrease the antihypertensive activities of Nitroglycerin.]
[A07DA03, loperamide, Loperamide may increase the vasodilatory activities of Nitroglycerin.]
[V04CC02, magnesium sulfate, Magnesium sulfate may increase the vasodilatory activities of Nitroglycerin.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Mannitol.]
[C02BB01, mecamylamine, Mecamylamine may increase the hypotensive activities of Nitroglycerin.]
[M02AA18, meclofenamic acid, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Meclofenamic acid.]
[C01CA11, mephentermine, Mephentermine may decrease the antihypertensive activities of Nitroglycerin.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Nitroglycerin.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Mepivacaine.]
[N05AX13, paliperidone, Paliperidone may decrease the antihypertensive activities of Nitroglycerin.]
[C01CA09, metaraminol, Metaraminol may decrease the antihypertensive activities of Nitroglycerin.]
[N06BA03, methamphetamine, Metamfetamine may decrease the antihypertensive activities of Nitroglycerin.]
[S01EC05, methazolamide, The risk or severity of adverse effects can be increased when Methazolamide is combined with Nitroglycerin.]
[G02CB05, metergoline, The bioavailability of Metergoline can be increased when combined with Nitroglycerin.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Nitroglycerin.]
[N05AA02, methotrimeprazine, Methotrimeprazine may decrease the antihypertensive activities of Nitroglycerin.]
[C01CA10, methoxamine, Methoxamine may decrease the antihypertensive activities of Nitroglycerin.]
[N02BG09, methoxyflurane, Methoxyflurane may decrease the antihypertensive activities of Nitroglycerin.]
[C03AA08, methyclothiazide, The therapeutic efficacy of Nitroglycerin can be increased when used in combination with Methyclothiazide.]
[C02AB01, methyldopa, Nitroglycerin may increase the hypotensive activities of Methyldopa.]
[V04CG05, methylene blue, Methylene blue may increase the hypotensive activities of Nitroglycerin.]
[G02AB01, methylergonovine, The bioavailability of Methylergometrine can be increased when combined with Nitroglycerin.]
[N06BA04, methylphenidate, Methylphenidate may decrease the antihypertensive activities of Nitroglycerin.]
[N02CA04, methysergide, The bioavailability of Methysergide can be increased when combined with Nitroglycerin.]
[A03FA01, metoclopramide, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Metoclopramide.]
[C03BA08, metolazone, Metolazone may increase the hypotensive activities of Nitroglycerin.]
[C07AB02, metoprolol, Metoprolol may increase the hypotensive activities of Nitroglycerin.]
[N06AX03, mianserin, Mianserin may decrease the antihypertensive activities of Nitroglycerin.]
[N02BB03, aminopyrine, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Aminophenazone.]
[C01CA17, midodrine, Midodrine may decrease the antihypertensive activities of Nitroglycerin.]
[C09CA03, valsartan, Valsartan may increase the hypotensive activities of Nitroglycerin.]
[D11AX01, minoxidil, Minoxidil may increase the hypotensive activities of Nitroglycerin.]
[N06BA12, lisdexamfetamine, Lisdexamfetamine may decrease the antihypertensive activities of Nitroglycerin.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nitroglycerin.]
[C01DX12, molsidomine, Molsidomine may increase the hypotensive activities of Nitroglycerin.]
[C01BD01, amiodarone, Amiodarone may increase the vasodilatory activities of Nitroglycerin.]
[N06AA09, amitriptyline, Amitriptyline may decrease the antihypertensive activities of Nitroglycerin.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Nitroglycerin.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Nitroglycerin.]
[G04CA04, silodosin, The risk or severity of orthostatic hypotension and dizziness can be increased when Nitroglycerin is combined with Silodosin.]
[N06AA17, amoxapine, Amoxapine may decrease the antihypertensive activities of Nitroglycerin.]
[C07AA12, nadolol, Nitroglycerin may increase the hypotensive activities of Nadolol.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Ropinirole is combined with Nitroglycerin.]
[S01GA01, naphazoline, Naphazoline may decrease the antihypertensive activities of Nitroglycerin.]
[N06BA01, amphetamine, Amphetamine may decrease the antihypertensive activities of Nitroglycerin.]
[M02AA12, naproxen, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Naproxen.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Nitroglycerin is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Nitroglycerin.]
[N01AH06, remifentanil, Remifentanil may decrease the antihypertensive activities of Nitroglycerin.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Levosimendan.]
[N05AX14, iloperidone, Iloperidone may decrease the antihypertensive activities of Nitroglycerin.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nitroglycerin.]
[C09CA07, telmisartan, Nitroglycerin may increase the hypotensive activities of Telmisartan.]
[N06AF02, nialamide, Nialamide may increase the hypotensive activities of Nitroglycerin.]
[C08CA04, nicardipine, Nicardipine may increase the vasodilatory activities of Nitroglycerin.]
[C04AE02, nicergoline, The bioavailability of Nicergoline can be increased when combined with Nitroglycerin.]
[C08CA05, nifedipine, Nifedipine may increase the vasodilatory activities of Nitroglycerin.]
[M02AA17, niflumic acid, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Niflumic acid.]
[V03AB22, amyl nitrite, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Amyl Nitrite.]
[C08CA06, nimodipine, Nimodipine may increase the vasodilatory activities of Nitroglycerin.]
[C08CA07, nisoldipine, Nisoldipine may increase the vasodilatory activities of Nitroglycerin.]
[C08CA08, nitrendipine, Nitrendipine may increase the vasodilatory activities of Nitroglycerin.]
[R07AX01, nitric oxide, The risk or severity of methemoglobinemia can be increased when Nitric Oxide is combined with Nitroglycerin.]
[J01XE01, nitrofurantoin, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Nitroglycerin.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Pramipexole is combined with Nitroglycerin.]
[C02DD01, nitroprusside, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Nitroglycerin.]
[N01AX13, nitrous oxide, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Nitrous oxide.]
[C01CA03, norepinephrine, Norepinephrine may decrease the antihypertensive activities of Nitroglycerin.]
[C02KX01, bosentan, Bosentan may increase the hypotensive activities of Nitroglycerin.]
[N06AA10, nortriptyline, Nortriptyline may decrease the antihypertensive activities of Nitroglycerin.]
[G02CA02, nylidrin, Nylidrin may increase the vasodilatory activities of Nitroglycerin.]
[N06AA05, opipramol, Opipramol may decrease the antihypertensive activities of Nitroglycerin.]
[R03CB03, metaproterenol, Orciprenaline may decrease the antihypertensive activities of Nitroglycerin.]
[B01AD07, reteplase, The therapeutic efficacy of Reteplase can be decreased when used in combination with Nitroglycerin.]
[G04CA02, tamsulosin, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Nitroglycerin.]
[C07AA02, oxprenolol, Nitroglycerin may increase the hypotensive activities of Oxprenolol.]
[C01DX03, oxyfedrine, Oxyfedrine may decrease the antihypertensive activities of Nitroglycerin.]
[S01GA04, oxymetazoline, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Oxymetazoline.]
[S01BC02, oxyphenbutazone, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Oxyphenbutazone.]
[J04AA01, aminosalicylic acid, The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Nitroglycerin.]
[N05AH05, asenapine, Asenapine may decrease the antihypertensive activities of Nitroglycerin.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Papaverine.]
[C02KC01, pargyline, Pargyline may increase the hypotensive activities of Nitroglycerin.]
[C07AA23, penbutolol, Nitroglycerin may increase the hypotensive activities of Penbutolol.]
[N05AG03, penfluridol, Penfluridol may increase the vasodilatory activities of Nitroglycerin.]
[N05CA01, pentobarbital, Pentobarbital may increase the hypotensive activities of Nitroglycerin.]
[C04AD03, pentoxifylline, Pentoxifylline may increase the hypotensive activities of Nitroglycerin.]
[N04BC02, pergolide, The bioavailability of Pergolide can be increased when combined with Nitroglycerin.]
[C08EX02, perhexiline, Perhexiline may increase the vasodilatory activities of Nitroglycerin.]
[G04BX06, phenazopyridine, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Phenazopyridine.]
[N06AF03, phenelzine, Phenelzine may increase the hypotensive activities of Nitroglycerin.]
[N03AA02, phenobarbital, Phenobarbital may increase the hypotensive activities of Nitroglycerin.]
[C04AX02, phenoxybenzamine, Phenoxybenzamine may decrease the antihypertensive activities of Nitroglycerin.]
[A08AA01, phentermine, Phentermine may decrease the antihypertensive activities of Nitroglycerin.]
[V03AB36, phentolamine, Phentolamine may decrease the antihypertensive activities of Nitroglycerin.]
[M02AA01, phenylbutazone, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Phenylbutazone.]
[S01GA05, phenylephrine, Phenylephrine may decrease the antihypertensive activities of Nitroglycerin.]
[R01BA01, phenylpropanolamine, Phenylpropanolamine may decrease the antihypertensive activities of Nitroglycerin.]
[N03AB02, phenytoin, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Nitroglycerin.]
[C08CX01, mibefradil, Mibefradil may increase the vasodilatory activities of Nitroglycerin.]
[C07AA03, pindolol, Nitroglycerin may increase the hypotensive activities of Pindolol.]
[C09CA02, eprosartan, Nitroglycerin may increase the hypotensive activities of Eprosartan.]
[S01BC06, piroxicam, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Piroxicam.]
[N02CX01, pizotyline, Pizotifen may decrease the antihypertensive activities of Nitroglycerin.]
[C09CA04, irbesartan, Nitroglycerin may increase the hypotensive activities of Irbesartan.]
[S01XA13, alteplase, The serum concentration of Alteplase can be decreased when it is combined with Nitroglycerin.]
[A10BG02, rosiglitazone, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Rosiglitazone.]
[C03AA05, polythiazide, The therapeutic efficacy of Nitroglycerin can be increased when used in combination with Polythiazide.]
[C07AB01, practolol, Nitroglycerin may increase the hypotensive activities of Practolol.]
[C02CA01, prazosin, The risk or severity of hypotension can be increased when Prazosin is combined with Nitroglycerin.]
[C01DX02, prenylamine, Prenylamine may increase the vasodilatory activities of Nitroglycerin.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Prilocaine.]
[P01BA03, primaquine, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Primaquine.]
[N03AA03, primidone, Primidone may increase the hypotensive activities of Nitroglycerin.]
[S01HA05, procaine, Procaine may increase the hypotensive activities of Nitroglycerin.]
[L01XB01, procarbazine, Procarbazine may increase the hypotensive activities of Nitroglycerin.]
[N05AA03, promazine, Promazine may decrease the antihypertensive activities of Nitroglycerin.]
[C01BC03, propafenone, Propafenone may decrease the antihypertensive activities of Nitroglycerin.]
[N05AC01, periciazine, Periciazine may decrease the antihypertensive activities of Nitroglycerin.]
[N05CM06, propiomazine, Propiomazine may decrease the antihypertensive activities of Nitroglycerin.]
[N01AX10, propofol, Propofol may decrease the antihypertensive activities of Nitroglycerin.]
[C07AA05, propranolol, Propranolol may increase the hypotensive activities of Nitroglycerin.]
[N02CC04, rizatriptan, Rizatriptan may decrease the antihypertensive activities of Nitroglycerin.]
[B01AC09, epoprostenol, Epoprostenol may increase the hypotensive activities of Nitroglycerin.]
[N06AA11, protriptyline, Protriptyline may decrease the antihypertensive activities of Nitroglycerin.]
[R01BA02, pseudoephedrine, Pseudoephedrine may decrease the antihypertensive activities of Nitroglycerin.]
[N05AX12, aripiprazole, The risk or severity of hypotension can be increased when Aripiprazole is combined with Nitroglycerin.]
[C01BA01, quinidine, Quinidine may decrease the antihypertensive activities of Nitroglycerin.]
[P01BC01, quinine, The risk or severity of methemoglobinemia can be increased when Quinine is combined with Nitroglycerin.]
[C02AA01, rescinnamine, Rescinnamine may decrease the antihypertensive activities of Nitroglycerin.]
[C02AA02, reserpine, Reserpine may increase the hypotensive activities of Nitroglycerin.]
[R03AC05, rimiterol, Rimiterol may decrease the antihypertensive activities of Nitroglycerin.]
[G02CA01, ritodrine, Ritodrine may decrease the antihypertensive activities of Nitroglycerin.]
[N02BA05, salicylamide, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Salicylamide.]
[A07EC01, sulfasalazine, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Sulfasalazine.]
[S01BC08, salicylic acid, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Salicylic acid.]
[N05CA06, secobarbital, Secobarbital may increase the hypotensive activities of Nitroglycerin.]
[N04BD01, selegiline, Selegiline may increase the hypotensive activities of Nitroglycerin.]
[L01FA03, obinutuzumab, Nitroglycerin may increase the hypotensive activities of Obinutuzumab.]
[C07AA07, sotalol, The risk or severity of adverse effects can be increased when Sotalol is combined with Nitroglycerin.]
[C03DA01, spironolactone, The risk or severity of adverse effects can be increased when Spironolactone is combined with Nitroglycerin.]
[C01DA14, isosorbide mononitrate, Nitroglycerin may increase the vasodilatory activities of Isosorbide mononitrate.]
[M01AE11, tiaprofenic acid, The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Tiaprofenic acid.]
[C03CC01, ethacrynic acid, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Etacrynic acid.]
